Antidiabetic drug causes double the weight loss of competitor
Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.
Jul 1, 2021
0
7